Ocrevus® (ocrelizumab)

In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: New Data on Previously Approved […]

Read News Article

Mavenclad® (cladribine)

In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: Medications Recently Approved Company: EMD […]

Read News Article

Mayzent® (siponimod)

In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: Medications Recently Approved Company: Novartis […]

Read News Article

MS Research Update 2019

In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References View/Download PDF View Digital Edition Written and […]

Read News Article
MSAA Art Showcase 2019

MSAA Recognizes Ten Years of Artwork from Individuals with Multiple Sclerosis

Started in 2009, the MSAA Art Showcases are comprised of two categories: the MS Ability Art Showcase and the Four Seasons Art Showcase. Artists with a diagnosis of MS are invited each fall to submit their best oil, watercolor, acrylic or pastel paintings, as well as drawings in ink or pencil. The artwork debuts on MSAA’s website, alongside the artists’ personal stories during MS Awareness Month every March.

Read News Article